Selected research
Industry Growth & Trends
Global Pregabalin Capsule Industry Growth and Trends Forecast to 2032
Market perspective
The global Pregabalin Capsule market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Pregabalin Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Pregabalin Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pregabalin Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pregabalin Capsule include Wan Vee Pharm, Succeway Pharmaceuticals, Qilu Pharmaceutical, Pfizer, Stat Rx USA, Angita Pharma, Actavis Pharma and Accord Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Pregabalin Capsule market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Pregabalin Capsule market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pregabalin Capsule market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pregabalin Capsule.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Pregabalin Capsule market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Pregabalin Capsule Market by Company
Wan Vee Pharm
Succeway Pharmaceuticals
Qilu Pharmaceutical
Pfizer
Stat Rx USA
Angita Pharma
Actavis Pharma
Accord Healthcare
Pregabalin Capsule Segment by Type
75mg Capsule
50mg Capsule
25mg Capsule
Others
Pregabalin Capsule Segment by Application
Clinics
Hospitals
Others
Pregabalin Capsule Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pregabalin Capsule market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pregabalin Capsule and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pregabalin Capsule.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pregabalin Capsule manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Pregabalin Capsule in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 75mg Capsule
- 50mg Capsule
- 25mg Capsule
- Others
Applications
- Clinics
- Hospitals
- Others
Companies covered
- Wan Vee Pharm
- Succeway Pharmaceuticals
- Qilu Pharmaceutical
- Pfizer
- Stat Rx USA
- Angita Pharma
- Actavis Pharma
- Accord Healthcare
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Pregabalin Capsule Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Pregabalin Capsule Sales Estimates and Forecasts (2021-2032)
- 1.3 Pregabalin Capsule Market by Type
- 1.3.1 75mg Capsule
- 1.3.2 50mg Capsule
- 1.3.3 25mg Capsule
- 1.3.4 Others
- 1.4 Global Pregabalin Capsule Market Size by Type
- 1.4.1 Global Pregabalin Capsule Market Size Overview by Type (2021-2032)
- 1.4.2 Global Pregabalin Capsule Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Pregabalin Capsule Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Pregabalin Capsule Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Pregabalin Capsule Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Pregabalin Capsule Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Pregabalin Capsule Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Pregabalin Capsule Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Pregabalin Capsule Industry Trends
- 2.2 Pregabalin Capsule Industry Drivers
- 2.3 Pregabalin Capsule Industry Opportunities and Challenges
- 2.4 Pregabalin Capsule Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Pregabalin Capsule Revenue (2021-2026)
- 3.2 Global Top Players by Pregabalin Capsule Sales (2021-2026)
- 3.3 Global Top Players by Pregabalin Capsule Price (2021-2026)
- 3.4 Global Pregabalin Capsule Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pregabalin Capsule Major Company Production Sites & Headquarters
- 3.6 Global Pregabalin Capsule Company, Product Type & Application
- 3.7 Global Pregabalin Capsule Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Pregabalin Capsule Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Pregabalin Capsule Players Market Share by Revenue in 2025
- 3.8.3 2025 Pregabalin Capsule Tier 1, Tier 2, and Tier 3
4 Pregabalin Capsule Regional Status and Outlook
- 4.1 Global Pregabalin Capsule Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Pregabalin Capsule Historic Market Size by Region
- 4.2.1 Global Pregabalin Capsule Sales in Volume by Region (2021-2026)
- 4.2.2 Global Pregabalin Capsule Sales in Value by Region (2021-2026)
- 4.2.3 Global Pregabalin Capsule Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Pregabalin Capsule Forecasted Market Size by Region
- 4.3.1 Global Pregabalin Capsule Sales in Volume by Region (2027-2032)
- 4.3.2 Global Pregabalin Capsule Sales in Value by Region (2027-2032)
- 4.3.3 Global Pregabalin Capsule Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pregabalin Capsule by Application
- 5.1 Pregabalin Capsule Market by Application
- 5.1.1 Clinics
- 5.1.2 Hospitals
- 5.1.3 Others
- 5.2 Global Pregabalin Capsule Market Size by Application
- 5.2.1 Global Pregabalin Capsule Market Size Overview by Application (2021-2032)
- 5.2.2 Global Pregabalin Capsule Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Pregabalin Capsule Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Pregabalin Capsule Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Pregabalin Capsule Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Pregabalin Capsule Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Pregabalin Capsule Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Pregabalin Capsule Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Wan Vee Pharm
- 6.1.1 Wan Vee Pharm Company Information
- 6.1.2 Wan Vee Pharm Business Overview
- 6.1.3 Wan Vee Pharm Pregabalin Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Wan Vee Pharm Pregabalin Capsule Product Portfolio
- 6.1.5 Wan Vee Pharm Recent Developments
- 6.2 Succeway Pharmaceuticals
- 6.2.1 Succeway Pharmaceuticals Company Information
- 6.2.2 Succeway Pharmaceuticals Business Overview
- 6.2.3 Succeway Pharmaceuticals Pregabalin Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Succeway Pharmaceuticals Pregabalin Capsule Product Portfolio
- 6.2.5 Succeway Pharmaceuticals Recent Developments
- 6.3 Qilu Pharmaceutical
- 6.3.1 Qilu Pharmaceutical Company Information
- 6.3.2 Qilu Pharmaceutical Business Overview
- 6.3.3 Qilu Pharmaceutical Pregabalin Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Qilu Pharmaceutical Pregabalin Capsule Product Portfolio
- 6.3.5 Qilu Pharmaceutical Recent Developments
- 6.4 Pfizer
- 6.4.1 Pfizer Company Information
- 6.4.2 Pfizer Business Overview
- 6.4.3 Pfizer Pregabalin Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Pfizer Pregabalin Capsule Product Portfolio
- 6.4.5 Pfizer Recent Developments
- 6.5 Stat Rx USA
- 6.5.1 Stat Rx USA Company Information
- 6.5.2 Stat Rx USA Business Overview
- 6.5.3 Stat Rx USA Pregabalin Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Stat Rx USA Pregabalin Capsule Product Portfolio
- 6.5.5 Stat Rx USA Recent Developments
- 6.6 Angita Pharma
- 6.6.1 Angita Pharma Company Information
- 6.6.2 Angita Pharma Business Overview
- 6.6.3 Angita Pharma Pregabalin Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Angita Pharma Pregabalin Capsule Product Portfolio
- 6.6.5 Angita Pharma Recent Developments
- 6.7 Actavis Pharma
- 6.7.1 Actavis Pharma Company Information
- 6.7.2 Actavis Pharma Business Overview
- 6.7.3 Actavis Pharma Pregabalin Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Actavis Pharma Pregabalin Capsule Product Portfolio
- 6.7.5 Actavis Pharma Recent Developments
- 6.8 Accord Healthcare
- 6.8.1 Accord Healthcare Company Information
- 6.8.2 Accord Healthcare Business Overview
- 6.8.3 Accord Healthcare Pregabalin Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Accord Healthcare Pregabalin Capsule Product Portfolio
- 6.8.5 Accord Healthcare Recent Developments
7 North America by Country
- 7.1 North America Pregabalin Capsule Sales by Country
- 7.1.1 North America Pregabalin Capsule Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Pregabalin Capsule Sales by Country (2021-2026)
- 7.1.3 North America Pregabalin Capsule Sales Forecast by Country (2027-2032)
- 7.2 North America Pregabalin Capsule Market Size by Country
- 7.2.1 North America Pregabalin Capsule Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Pregabalin Capsule Market Size by Country (2021-2026)
- 7.2.3 North America Pregabalin Capsule Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Pregabalin Capsule Sales by Country
- 8.1.1 Europe Pregabalin Capsule Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Pregabalin Capsule Sales by Country (2021-2026)
- 8.1.3 Europe Pregabalin Capsule Sales Forecast by Country (2027-2032)
- 8.2 Europe Pregabalin Capsule Market Size by Country
- 8.2.1 Europe Pregabalin Capsule Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Pregabalin Capsule Market Size by Country (2021-2026)
- 8.2.3 Europe Pregabalin Capsule Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Pregabalin Capsule Sales by Country
- 9.1.1 Asia-Pacific Pregabalin Capsule Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Pregabalin Capsule Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Pregabalin Capsule Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Pregabalin Capsule Market Size by Country
- 9.2.1 Asia-Pacific Pregabalin Capsule Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Pregabalin Capsule Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Pregabalin Capsule Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Pregabalin Capsule Sales by Country
- 10.1.1 South America Pregabalin Capsule Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Pregabalin Capsule Sales by Country (2021-2026)
- 10.1.3 South America Pregabalin Capsule Sales Forecast by Country (2027-2032)
- 10.2 South America Pregabalin Capsule Market Size by Country
- 10.2.1 South America Pregabalin Capsule Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Pregabalin Capsule Market Size by Country (2021-2026)
- 10.2.3 South America Pregabalin Capsule Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Pregabalin Capsule Sales by Country
- 11.1.1 Middle East and Africa Pregabalin Capsule Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Pregabalin Capsule Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Pregabalin Capsule Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Pregabalin Capsule Market Size by Country
- 11.2.1 Middle East and Africa Pregabalin Capsule Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Pregabalin Capsule Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Pregabalin Capsule Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Pregabalin Capsule Value Chain Analysis
- 12.1.1 Pregabalin Capsule Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Pregabalin Capsule Production Mode & Process
- 12.2 Pregabalin Capsule Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Pregabalin Capsule Distributors
- 12.2.3 Pregabalin Capsule Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst